Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Sex- and gender-related differences in psoriatic arthritis

Nature Reviews Rheumatology volume 18, pages 513–526 (2022)Cite this article

Subjects

Abstract

Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease with a chronic, progressive course. Various aspects of PsA, including its clinical features, disease course and response to treatment, are influenced by sociodemographic characteristics of the patient. This includes patient sex, the biological attributes associated with being male or female, and gender, a sociocultural construct that comprises attitudes, traits and behaviours associated with being a man or a woman. An understanding of sex- and gender-related differences in PsA, as well as their underlying mechanisms, is therefore important for individualized care. In this narrative review, the influence of sex and gender on PsA manifestation and course, patient function and quality of life, and their association with comorbidities are described. Sex- and gender-related disparities in response to advanced therapies and their potential underlying mechanisms are delineated. Differences in pathophysiological mechanisms between male and female patients including genetics, immune and hormonal mechanisms are discussed. Finally, fertility and pregnancy outcomes in PsA are outlined. By adopting sex and gender lenses, this review is aimed at highlighting key differences between male and female patients with PsA and uncovering mechanisms underlying these differences, ultimately promoting individualized care of men and women with PsA and informing future research in this area.

Key points

  • The majority of studies show that peripheral arthritis is more common in female patients with PsA, whereas axial disease and severe psoriasis are more common in male patients, emphasizing the need for specific sex-gender considerations in diagnosis and treatment selection.

  • Female patients with PsA are less likely to develop radiographic damage in axial and peripheral joints than male patients, and therefore require more sensitive imaging modalities (such as MRI and ultrasound) for diagnosis.

  • Higher levels of pain, fatigue, poor functional status and worse quality of life in female patients with PsA have been reported compared with male patients. Women with PsA might require psycho-social support, occupational modification and targeted pain management.

  • Female patients with PsA are at a higher risk of discontinuing or switching advanced therapy than male patients, thereby necessitating closer monitoring after drug initiation.

  • Parameters of PsA disease activity improve during pregnancy and flare up during the postpartum period, emphasizing the need for close monitoring after pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Sex- and gender-related mechanisms and disease outcomes in PsA.

Similar content being viewed by others

References

  1. Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N. Engl. J. Med. 376, 957–970 (2017). An updated review on PsA.

    Article  PubMed  Google Scholar 

  2. Colombo, D., Cassano, N., Bellia, G. & Vena, G. A. Gender medicine and psoriasis. World J. Dermatol. 3, 36–44 (2014).

    Article  Google Scholar 

  3. Moll, J. M. & Wright, V. Psoriatic arthritis. Semin. Arthritis Rheum. 3, 55–78 (1973).

    Article  CAS  PubMed  Google Scholar 

  4. Bem, S. L. The measurement of psychological androgyny. J. Consult. Clin. Psychol. 42, 155–162 (1974).

    Article  CAS  PubMed  Google Scholar 

  5. Johnson, J. L., Greaves, L. & Repta, R. Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research. Int. J. Equity Health 8, 14 (2009). An important article outlining sex and gender-based analysis in health research.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Litwic, A., Edwards, M., Dennison, E. & Cooper, C. Epidemiology and burden of osteoarthritis. Br. Med. Bull. 105, 185–199 (2013).

    Article  PubMed  Google Scholar 

  7. Fox, D and Moyser, M. Women in Canada: a gender-based statistical report. in The economic well-being of women in Canada (Statistics Canada, 2018).

  8. Badley, E. M., Canizares, M., Gunz, A. C. & Davis, A. M. Visits to rheumatologists for arthritis: the role of access to primary care physicians, geographic availability of rheumatologists, and socioeconomic status. Arthritis Care Res. 67, 230–239 (2015).

    Article  Google Scholar 

  9. Soriano, E. R. et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatol. Oxf. Engl. 50, 729–734 (2011).

    Article  Google Scholar 

  10. Nossent, J. C. & Gran, J. T. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand. J. Rheumatol. 38, 251–255 (2009).

    Article  CAS  PubMed  Google Scholar 

  11. Karmacharya, P. et al. The epidemiology of psoriatic arthritis over five decades: a population-based study. Arthritis Rheumatol. https://doi.org/10.1002/art.41741 (2021).

    Article  PubMed  Google Scholar 

  12. Yamamoto, T. et al. Epidemiological analysis of psoriatic arthritis patients in Japan. J. Dermatol. 43, 1193–1196 (2016).

    Article  PubMed  Google Scholar 

  13. Rajendran, C. P., Ledge, S. G., Rani, K. P. & Madhavan, R. Psoriatic arthritis. J. Assoc. Physicians India 51, 1065–1068 (2003).

    CAS  PubMed  Google Scholar 

  14. Eder, L. et al. The epidemiology of psoriatic arthritis in Israel — a population-based study. Arthritis Res. Ther. 20, 3 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Alamanos, Y. et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982–2001. J. Rheumatol. 30, 2641–2644 (2003).

    PubMed  Google Scholar 

  16. Kerola, A. M. et al. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Semin. Arthritis Rheum. 51, 1081–1088 (2021).

    Article  PubMed  Google Scholar 

  17. Grellmann, C. et al. Epidemiology and treatment of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in Germany: a real-world evidence study. Adv. Ther. 38, 366–385 (2021).

    Article  PubMed  Google Scholar 

  18. Pina Vegas, L., Sbidian, E., Penso, L. & Claudepierre, P. Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database. Rheumatol. Oxf. Engl. 60, 1243–1251 (2021).

    Article  Google Scholar 

  19. Egeberg, A. et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann. Rheum. Dis. 76, 1591–1597 (2017).

    Article  PubMed  Google Scholar 

  20. Tekin, H. G., Wu, J. J., Burge, R., Birt, J. & Egeberg, A. Burden and disease characteristics of patients with psoriatic arthritis: a population-based cross-sectional study. J. Rheumatol. 46, 716–720 (2019).

    Article  CAS  PubMed  Google Scholar 

  21. Love, T. J., Gudbjornsson, B., Gudjonsson, J. E. & Valdimarsson, H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J. Rheumatol. 34, 2082–2088 (2007).

    PubMed  Google Scholar 

  22. Kojanova, M. et al. Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech Republic. Dermatol. Ther. 34, e14849 (2021).

    Article  PubMed  Google Scholar 

  23. Dönmez, S., Pamuk, Ö. N., Akker, M. & Ak, R. Clinical features and types of articular involvement in patients with psoriatic arthritis. Clin. Rheumatol. 34, 1091–1096 (2015).

    Article  PubMed  Google Scholar 

  24. Ogdie, A. et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatol. Oxf. Engl. 52, 568–575 (2013).

    Article  Google Scholar 

  25. Theander, E. et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish early psoriatic arthritis register (SwePsA). Ann. Rheum. Dis. 73, 407–413 (2014).

    Article  PubMed  Google Scholar 

  26. Eder, L., Thavaneswaran, A., Chandran, V. & Gladman, D. D. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann. Rheum. Dis. 72, 578–582 (2013). This study was pivotal in describing important sex-related differences in clinical features, imaging and patient-reported outcomes in PsA.

    Article  PubMed  Google Scholar 

  27. Kalyoncu, U. et al. The psoriatic arthritis registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatol. Oxf. Engl. 56, 279–286 (2017).

    Article  Google Scholar 

  28. Nas, K. et al. Gender specific differences in patients with psoriatic arthritis. Mod. Rheumatol. 27, 345–349 (2017).

    Article  PubMed  Google Scholar 

  29. Duruöz, M. T. et al. Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: a multi-center study. Jt. Bone Spine 88, 105177 (2021).

    Article  Google Scholar 

  30. Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O. & Nash, P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann. Rheum. Dis. 64, ii14–ii17 (2005).

    PubMed  PubMed Central  Google Scholar 

  31. Møller, P. & Vinje, O. Arthropathy and sacro-iliitis in severe psoriasis. Scand. J. Rheumatol. 9, 113–117 (1980).

    Article  PubMed  Google Scholar 

  32. Mease, P. J. et al. Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J. Rheumatol. 45, 1389 (2018).

    Article  PubMed  Google Scholar 

  33. Mease, P. J. et al. Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care Res. 69, 1692–1699 (2017).

    Article  CAS  Google Scholar 

  34. Nas, K. et al. The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod. Rheumatol. 31, 869–874 (2021).

    Article  PubMed  Google Scholar 

  35. Orbai, A.-M. et al. Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with sex in 458 patients from fourteen countries. Arthritis Care Res. 72, 1772–1779 (2020).

    Article  Google Scholar 

  36. Perez-Chada, L. M. & Merola, J. F. Comorbidities associated with psoriatic arthritis: review and update. Clin. Immunol. 214, 108397 (2020).

    Article  CAS  PubMed  Google Scholar 

  37. Orbai, A.-M. et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann. Rheum. Dis. 76, 673–680 (2017).

    Article  PubMed  Google Scholar 

  38. Augustin, M. et al. Nail psoriasis in Germany: epidemiology and burden of disease. Br. J. Dermatol. 163, 580–585 (2010).

    Article  CAS  PubMed  Google Scholar 

  39. Hägg, D., Sundström, A., Eriksson, M. & Schmitt-Egenolf, M. Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish register patients. Am. J. Clin. Dermatol. 18, 583–590 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Maul, J.-T. et al. Efficacy and survival of systemic psoriasis treatments: an analysis of the Swiss registry SDNTT. Dermatol. Basel Switz. 232, 640–647 (2016).

    Article  CAS  Google Scholar 

  41. Hägg, D., Eriksson, M., Sundström, A. & Schmitt-Egenolf, M. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PLoS One 8, e63619 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Hernández-Fernández, C. et al. Effect of sex in systemic psoriasis therapy: differences in prescription, effectiveness and safety in the BIOBADADERM prospective cohort. Acta Derm. Venereol. 101, adv00354 (2021).

    Article  PubMed  Google Scholar 

  43. Ji, C. et al. Challenge of nail psoriasis: an update review. Clin. Rev. Allergy Immunol. 61, 377–402 (2021).

    Article  PubMed  Google Scholar 

  44. Martínez-Ortega, J. M. et al. Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study. J. Psychosom. Res. 124, 109780 (2019).

    Article  PubMed  Google Scholar 

  45. Zeboulon, N., Dougados, M. & Gossec, L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann. Rheum. Dis. 67, 955–959 (2008).

    Article  CAS  PubMed  Google Scholar 

  46. Queiro, R. et al. Clinical features and predictive factors in psoriatic arthritis-related uveitis. Semin. Arthritis Rheum. 31, 264–270 (2002).

    Article  PubMed  Google Scholar 

  47. Paiva, E. S., Macaluso, D. C., Edwards, A. & Rosenbaum, J. T. Characterisation of uveitis in patients with psoriatic arthritis. Ann. Rheum. Dis. 59, 67–70 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Egeberg, A. et al. Association of psoriatic disease with uveitis: a Danish nationwide cohort study. JAMA Dermatol. 151, 1200–1205 (2015).

    Article  PubMed  Google Scholar 

  49. Peluso, R. et al. Extra-articular manifestations in psoriatic arthritis patients. Clin. Rheumatol. 34, 745–753 (2015).

    Article  PubMed  Google Scholar 

  50. Bengtsson, K. et al. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study. Rheumatol. Oxf. Engl. 60, 2725–2734 (2021).

    Article  CAS  Google Scholar 

  51. Egeberg, A. et al. Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study. Br. J. Dermatol. 175, 487–492 (2016).

    Article  CAS  PubMed  Google Scholar 

  52. Geijer, M. et al. The Swedish early psoriatic arthritis registry 5-year followup: substantial radiographic progression mainly in men with high disease activity and development of dactylitis. J. Rheumatol. 42, 2110–2117 (2015). This study outlined important radiological differences in PsA between men and women.

    Article  CAS  PubMed  Google Scholar 

  53. Braaten, T. J. et al. Gender differences in psoriatic arthritis with fatigue, pain, function, and work disability. J. Psoriasis Psoriatic Arthritis 4, 192–197 (2019).

    Article  Google Scholar 

  54. Gudu, T. et al. Fatigue in psoriatic arthritis — a cross-sectional study of 246 patients from 13 countries. Jt. Bone Spine 83, 439–443 (2016).

    Article  Google Scholar 

  55. Kenar, G. et al. Gender does not make a difference in ‘composite psoriatic disease activity index (CPDAI)’ in patients with psoriatic arthritis. Rheumatol. Int. 38, 2069–2076 (2018).

    Article  CAS  PubMed  Google Scholar 

  56. Turner, D. E. et al. Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study. Rheumatol. Oxf. Engl. 53, 737–740 (2014).

    Article  Google Scholar 

  57. Tan, J. S. Q., Fong, W., Kwan, Y. H. & Leung, Y. Y. Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study. Rheumatol. Int. 40, 1825–1834 (2020).

    Article  CAS  PubMed  Google Scholar 

  58. Leung, Y. Y., Fong, W., Lui, N. L. & Thumboo, J. Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population. Clin. Rheumatol. 36, 125–131 (2017).

    Article  PubMed  Google Scholar 

  59. Wallenius, M. et al. Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann. Rheum. Dis. 68, 685–689 (2009).

    Article  CAS  PubMed  Google Scholar 

  60. Kristensen, L. E. et al. Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. Ann. Rheum. Dis. 72, 1675–1679 (2013).

    Article  CAS  PubMed  Google Scholar 

  61. Verstappen, S. M. M. et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology 49, 1570–1577 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ulus, Y., Akyol, Y., Bilgici, A. & Kuru, O. The impact of the presence of fibromyalgia on fatigue in patients with psoriatic arthritis: comparison with controls. Adv. Rheumatol. Lond. Engl. 60, 1 (2019).

    Google Scholar 

  63. Lindström Egholm, C. et al. Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician’s sex: data on patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis from the DANBIO registry. J. Rheumatol. 42, 1781–1785 (2015).

    Article  PubMed  CAS  Google Scholar 

  64. Michelsen, B. et al. Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatol. Oxf. Engl. 59, 2455–2461 (2020).

    Article  CAS  Google Scholar 

  65. Desthieux, C. et al. Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European Study. Arthritis Care Res. 69, 1606–1611 (2017).

    Article  Google Scholar 

  66. Wang, C. T. M., Kwan, Y. H., Fong, W., Xiong, S. Q. & Leung, Y. Y. Factors associated with patient-physician discordance in a prospective cohort of patients with psoriatic arthritis: an Asian perspective. Int. J. Rheum. Dis. 22, 1209–1215 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  67. Widdifield, J. et al. Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. BMJ Open 4, e003888 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  68. Rida, M. A. & Chandran, V. Challenges in the clinical diagnosis of psoriatic arthritis. Clin. Immunol. 214, 108390 (2020).

    Article  CAS  PubMed  Google Scholar 

  69. Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B. & O’Dell, J. R. (eds) Psoriatic Arthritis. in Kelley and Firestein’s Textbook of Rheumatology 1459–1486 (Elsevier, 2017).

  70. Bain, B. J. Some influences on the ESR and the fibrinogen level in healthy subjects. Clin. Lab. Haematol. 5, 45–54 (1983).

    Article  CAS  PubMed  Google Scholar 

  71. Johnson, S. R., Schentag, C. T. & Gladman, D. D. Autoantibodies in biological agent naive patients with psoriatic arthritis. Ann. Rheum. Dis. 64, 770–772 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Landi, M. et al. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. Medicine 95, e5652 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Pattison, E., Harrison, B. J., Griffiths, C. E. M., Silman, A. J. & Bruce, I. N. Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann. Rheum. Dis. 67, 672–676 (2008).

    Article  CAS  PubMed  Google Scholar 

  74. Ortolan, A. et al. Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort. Arthritis Res. Ther. 20, 218 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  75. Tournadre, A. et al. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort. Arthritis Care Res. 65, 1482–1489 (2013).

    Article  CAS  Google Scholar 

  76. Diaz, P., Feld, J., Eshed, I. & Eder, L. Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findings. RMD Open 8, e002011 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  77. Agten, C. A. et al. Postpartum bone marrow edema at the sacroiliac joints may mimic sacroiliitis of axial spondyloarthritis on MRI. Am. J. Roentgenol. 211, 1306–1312 (2018).

    Article  Google Scholar 

  78. Rusman, T., van Bentum, R. E. & van der Horst-Bruinsma, I. E. Sex and gender differences in axial spondyloarthritis: myths and truths. Rheumatology 59, iv38–iv46 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  79. Mathew, A. J., Østergaard, M. & Eder, L. Imaging in psoriatic arthritis: status and recent advances. Best. Pract. Res. Clin. Rheumatol. 35, 101690 (2021).

    Article  PubMed  Google Scholar 

  80. Arout, C. A., Sofuoglu, M., Bastian, L. A. & Rosenheck, R. A. Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans health administration study. J. Womens Health 27, 1035–1044 (2018).

    Article  Google Scholar 

  81. Mease, P. J. et al. Comparison of men and women with axial spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J. Rheumatol. 48, 1528–1536 (2021).

    Article  PubMed  Google Scholar 

  82. Arslan Alhussain, F. et al. Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound. Rheumatology 58, 299–303 (2019).

    PubMed  Google Scholar 

  83. Sapsford, M., Evans, J., Clunie, G. & Jadon, D. A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgia. Ther. Adv. Musculoskelet. Dis. 13, 1759720X211003812 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Passia, E. et al. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res. Ther. 24, 22 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. McGonagle, D., Hermann, K.-G. A. & Tan, A. L. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatol. Oxf. Engl. 54, 29–38 (2015).

    Article  CAS  Google Scholar 

  86. Saalfeld, W., Mixon, A. M., Zelie, J. & Lydon, E. J. Differentiating psoriatic arthritis from osteoarthritis and rheumatoid arthritis: a narrative review and guide for advanced practice providers. Rheumatol. Ther. 8, 1493–1517 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  87. Marchesoni, A. et al. The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia. Rheumatol. Oxf. Engl. 57, 32–40 (2018).

    Article  Google Scholar 

  88. Zhang, Y. & Jordan, J. M. Epidemiology of osteoarthritis. Clin. Geriatr. Med. 26, 355–369 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  89. Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 1–23 (2018).

    Google Scholar 

  90. Marques, A. P. et al. Prevalence of fibromyalgia: literature review update. Rev. Bras. Reumatol. Engl. Ed. 57, 356–363 (2017).

    Article  PubMed  Google Scholar 

  91. Pinkhasov, R. M. et al. Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. Int. J. Clin. Pract. 64, 475–487 (2010).

    Article  CAS  PubMed  Google Scholar 

  92. Samulowitz, A., Gremyr, I., Eriksson, E. & Hensing, G. “Brave Men” and “Emotional Women”: a theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain. Res. Manag. 2018, 6358624 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  93. Zhang, L., Losin, E. A. R., Ashar, Y. K., Koban, L. & Wager, T. D. Gender biases in estimation of others’ pain. J. Pain. 22, 1048–1059 (2021).

    Article  PubMed  Google Scholar 

  94. Chandran, S. et al. Prevalence and risk factors of low bone mineral density in psoriatic arthritis: a systematic review. Semin. Arthritis Rheum. 46, 174–182 (2016).

    Article  PubMed  Google Scholar 

  95. Zhu, T. Y., Li, E. K. & Tam, L.-S. Cardiovascular risk in patients with psoriatic arthritis. Int. J. Rheumatol. 2012, 714321 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  96. Maas, A. H. E. M. & Appelman, Y. E. A. Gender differences in coronary heart disease. Neth. Heart J. 18, 598–602 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Eder, L., Wu, Y., Chandran, V., Cook, R. & Gladman, D. D. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann. Rheum. Dis. 75, 1680–1686 (2016).

    Article  PubMed  Google Scholar 

  98. Fragoulis, G. E. et al. Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther. Adv. Musculoskelet. Dis. 12, 1759720×20976975 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  99. Fagerli, K. M. et al. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register. Rheumatol. Oxf. Engl. 58, 80–85 (2019).

    Article  Google Scholar 

  100. Özkan, S. G. et al. Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with psoriatic arthritis. Eur. J. Rheumatol. 4, 40–45 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  101. Dal Bello, G., Gisondi, P., Idolazzi, L. & Girolomoni, G. Psoriatic arthritis and diabetes mellitus: a narrative review. Rheumatol. Ther. 7, 271–285 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  102. Haque, N., Lories, R. J. & de Vlam, K. Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study. J. Rheumatol. 43, 376–382 (2016).

    Article  CAS  PubMed  Google Scholar 

  103. Roubille, C. et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 74, 480–489 (2015).

    Article  CAS  PubMed  Google Scholar 

  104. Yang, Z.-S., Lin, N.-N., Li, L. & Li, Y. The effect of TNF inhibitors on cardiovascular events in psoriasis and psoriatic arthritis: an updated meta-analysis. Clin. Rev. Allergy Immunol. 51, 240–247 (2016).

    Article  CAS  PubMed  Google Scholar 

  105. Rohekar, S. et al. Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum. 58, 82–87 (2008).

    Article  PubMed  Google Scholar 

  106. Hellgren, K. et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol. 66, 1282–1290 (2014).

    Article  CAS  PubMed  Google Scholar 

  107. Polachek, A. et al. Malignancy in psoriatic disease: results from prospective longitudinal cohorts. Semin. Arthritis Rheum. 51, 144–149 (2021).

    Article  PubMed  Google Scholar 

  108. Hagberg, K. W. et al. Rates of cancers and opportunistic infections in patients with psoriatic arthritis compared with patients without psoriatic arthritis. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 22, 241–247 (2016).

    Google Scholar 

  109. Haddad, A. et al. The incidence and predictors of infection in psoriasis and psoriatic arthritis: results from longitudinal observational cohorts. J. Rheumatol. 43, 362–366 (2016).

    Article  CAS  PubMed  Google Scholar 

  110. van Lunzen, J. & Altfeld, M. Sex differences in infectious diseases-common but neglected. J. Infect. Dis. 209 (Suppl 3), S79–S80 (2014).

    Article  PubMed  CAS  Google Scholar 

  111. Wu, C.-Y. et al. Depression and insomnia in patients with psoriasis and psoriatic arthritis taking tumor necrosis factor antagonists. Medicine 95, e3816 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Albert, P. R. Why is depression more prevalent in women? J. Psychiatry Neurosci. 40, 219–221 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  113. McLean, C. P., Asnaani, A., Litz, B. T. & Hofmann, S. G. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J. Psychiatr. Res. 45, 1027–1035 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  114. Mathew, A. J. & Chandran, V. Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation. Rheumatol. Ther. 7, 287–300 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  115. Lee, M.-S., Yeh, Y.-C., Chang, Y.-T. & Lai, M.-S. All-cause and cause-specific mortality in patients with psoriasis in Taiwan: a nationwide population-based study. J. Invest. Dermatol. 137, 1468–1473 (2017).

    Article  CAS  PubMed  Google Scholar 

  116. Haddad, A. et al. The association of psoriatic arthritis with all-cause mortality and leading causes of death in psoriatic arthritis. J. Rheumatol. https://doi.org/10.3899/jrheum.210159 (2021).

    Article  PubMed  Google Scholar 

  117. Mok, C. C., Kwok, C. L., Ho, L. Y., Chan, P. T. & Yip, S. F. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 63, 1182–1189 (2011).

    Article  CAS  PubMed  Google Scholar 

  118. Serdarevic, M., Striley, C. W. & Cottler, L. B. Gender differences in prescription opioid use. Curr. Opin. Psychiatry 30, 238–246 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  119. Dominick, K. L., Ahern, F. M., Gold, C. H. & Heller, D. A. Gender differences in NSAID use among older adults with osteoarthritis. Ann. Pharmacother. 37, 1566–1571 (2003).

    Article  PubMed  Google Scholar 

  120. Kingsley, G. H. & Scott, D. L. Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis — a systematic review. Psoriasis Auckl. NZ 5, 71–81 (2015).

    CAS  Google Scholar 

  121. Zardin-Moraes, M. et al. Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials: systematic review with metaanalysis. J. Rheumatol. 47, 839–846 (2020).

    Article  PubMed  Google Scholar 

  122. Mateo Soria, L. et al. Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital. Rheumatol. Int. 42, 1043–1051 (2022).

    Article  CAS  PubMed  Google Scholar 

  123. Chimenti, M. S. et al. A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors. Clin. Rheumatol. 36, 2253–2260 (2017).

    Article  PubMed  Google Scholar 

  124. Stober, C. et al. Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis. Rheumatol. Oxf. Engl. 57, 158–163 (2018).

    Article  CAS  Google Scholar 

  125. Iannone, F. et al. Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings. J. Rheumatol. 43, 911–917 (2016).

    Article  PubMed  CAS  Google Scholar 

  126. Flouri, I. D. et al. Comparative analysis and predictors of 10-year tumor necrosis factor inhibitors drug survival in patients with spondyloarthritis: first-year response predicts longterm drug persistence. J. Rheumatol. 45, 785–794 (2018).

    Article  CAS  PubMed  Google Scholar 

  127. Glintborg, B. et al. Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum. 63, 382–390 (2011).

    Article  PubMed  Google Scholar 

  128. Saad, A. A. et al. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Res. Ther. 11, R52 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  129. Saad, A. A. et al. Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register. Rheumatol. Oxf. Engl. 49, 697–705 (2010).

    Article  CAS  Google Scholar 

  130. Van den Bosch, F. et al. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann. Rheum. Dis. 69, 394–399 (2010).

    Article  PubMed  CAS  Google Scholar 

  131. da Silva, M. R. R. et al. Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations. Expert. Rev. Clin. Immunol. 15, 879–887 (2019).

    Article  PubMed  Google Scholar 

  132. Ribeiro da Silva, M. R. et al. Medication persistence for psoriatic arthritis in a Brazilian real-world setting. Future Sci. OA 5, FSO369 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  133. Fagerli, K. M. et al. Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register. RMD Open. 4, e000596 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  134. Favalli, E. G. et al. Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis: a multicenter retrospective analysis. Arthritis Care Res. 69, 867–874 (2017).

    Article  CAS  Google Scholar 

  135. Haddad, A. et al. Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis. Arthritis Care Res. 67, 842–847 (2015).

    Article  CAS  Google Scholar 

  136. Iannone, F. et al. Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA. Jt. Bone Spine 88, 105062 (2021).

    Article  CAS  Google Scholar 

  137. Lubrano, E., Parsons, W. J. & Perrotta, F. M. Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors. J. Rheumatol. 43, 918–923 (2016).

    Article  PubMed  CAS  Google Scholar 

  138. Perrotta, F. M., Marchesoni, A. & Lubrano, E. Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-α drugs. J. Rheumatol. 43, 350–355 (2016).

    Article  CAS  PubMed  Google Scholar 

  139. Vieira-Sousa, E. et al. Real-world longterm effectiveness of tumor necrosis factor inhibitors in psoriatic arthritis patients from the rheumatic diseases Portuguese register. J. Rheumatol. 47, 690–700 (2020).

    Article  CAS  PubMed  Google Scholar 

  140. Højgaard, P. et al. Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers. Rheumatol. Oxf. Engl. 57, 1651–1660 (2018). The first study investigating sex differences in treatment response to biologics in PsA.

    Article  Google Scholar 

  141. Ramonda, R. et al. Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study. RMD Open 7, e001519 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  142. Navarini, L. et al. Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23 R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting. Clin. Rheumatol. 39, 2663–2670 (2020).

    Article  PubMed  Google Scholar 

  143. Geale, K. et al. Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden. Rheumatol. Adv. Pract. 4, rkaa070 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  144. Favalli, E. G. et al. Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients. Clin. Exp. Rheumatol. 38, 19–26 (2020).

    PubMed  Google Scholar 

  145. Mease, P. J. et al. Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. RMD Open 4, e000638 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  146. Murray, K. et al. Long-term remission and biologic persistence rates: 12-year real-world data. Arthritis Res. Ther. 23, 25 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Glintborg, B. et al. Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry. Arthritis Rheum. 65, 1213–1223 (2013).

    Article  CAS  PubMed  Google Scholar 

  148. Sewerin, P., Borchert, K., Meise, D., Schneider, M. & Mahlich, J. Real-world treatment persistence with biologic disease-modifying antirheumatic drugs among German patients with psoriatic arthritis — a retrospective database study. Rheumatol. Ther. 8, 483–497 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  149. Michelsen, B. et al. Four-year follow-up of inflammatory arthropathy patients treated with golimumab: data from the observational multicentre NOR-DMARD study. Semin. Arthritis Rheum. 50, 12–16 (2020).

    Article  CAS  PubMed  Google Scholar 

  150. Iannone, F. et al. Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA. Scand. J. Rheumatol. 44, 192–199 (2015).

    Article  CAS  PubMed  Google Scholar 

  151. D’Angelo, S. et al. Effectiveness of adalimumab for the treatment of psoriatic arthritis: an Italian real-life retrospective study. Front. Pharmacol. 10, 1497 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  152. Sokka, T. et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res. Ther. 11, R7 (2009).

    PubMed  PubMed Central  Google Scholar 

  153. Rusman, T., van Vollenhoven, R. F. & van der Horst-Bruinsma, I. E. Gender differences in axial spondyloarthritis: women are not so lucky. Curr. Rheumatol. Rep. 20, 35 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).

    Article  CAS  PubMed  Google Scholar 

  155. Klein, S. L. & Morgan, R. The impact of sex and gender on immunotherapy outcomes. Biol. Sex. Differ. 11, 24 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  156. Strand, V., Goncalves, J. & Isaacs, J. D. Immunogenicity of biologic agents in rheumatology. Nat. Rev. Rheumatol. 17, 81–97 (2021).

    Article  PubMed  Google Scholar 

  157. Hiltunen, J. et al. Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis. Rheumatol. Int. 42, 1015–1025 (2022).

    Article  CAS  PubMed  Google Scholar 

  158. Murage, M. J. et al. Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Prefer. Adherence 12, 1483–1503 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  159. de Vries, S. T. et al. Sex differences in adverse drug reactions reported to the national pharmacovigilance centre in the Netherlands: an explorative observational study. Br. J. Clin. Pharmacol. 85, 1507–1515 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  160. Kim, J.-R. & Kim, H. A. Molecular mechanisms of sex-related differences in arthritis and associated pain. Int. J. Mol. Sci. 21, E7938 (2020). This Review summarizes sex-related differences in the pathogenesis of arthritis and pain relevant to PsA.

    Article  PubMed  CAS  Google Scholar 

  161. Nascimento, M. G., Kosminsky, M. & Chi, M. Gender role in pain perception and expression: an integrative review. BrJP 3, 58–62 (2020).

    Article  Google Scholar 

  162. Queiro, R. et al. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study. Arthritis Res. Ther. 19, 72 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  163. O’Rielly, D. D. & Rahman, P. Genetics of psoriatic arthritis. Best. Pract. Res. Clin. Rheumatol. 28, 673–685 (2014).

    Article  PubMed  Google Scholar 

  164. Rahman, P., Gladman, D. D., Schentag, C. T. & Petronis, A. Excessive paternal transmission in psoriatic arthritis. Arthritis Rheum. 42, 1228–1231 (1999). This study reported sexual dimorphism in inheritance patterns in PsA.

    Article  CAS  PubMed  Google Scholar 

  165. Pollock, R. A. et al. Further evidence supporting a parent-of-origin effect in psoriatic disease. Arthritis Care Res. 67, 1586–1590 (2015).

    Article  Google Scholar 

  166. Karason, A. et al. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am. J. Hum. Genet. 72, 125–131 (2003).

    Article  CAS  PubMed  Google Scholar 

  167. Scher, J. U., Ogdie, A., Merola, J. F. & Ritchlin, C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat. Rev. Rheumatol. 15, 153–166 (2019).

    Article  PubMed  Google Scholar 

  168. Eder, L. et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res. 63, 1091–1097 (2011).

    Article  Google Scholar 

  169. Oertelt-Prigione, S. in Principles of Gender-Specific Medicine 3rd edn (ed. Legato, M. J.), Ch. 21, 309–321 (Academic Press, 2017).

  170. Taneja, V. Sex hormones determine immune response. Front. Immunol. 9, 1931 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  171. Cornelius, D. C. in Sex Differences in Cardiovascular Physiology and Pathophysiology (eds LaMarca, B. & Alexander, B. T.), Ch. 3, 205–217 (Academic Press, 2019).

  172. Lefèvre, N. et al. The number of X chromosomes influences inflammatory cytokine production following toll-like receptor stimulation. Front. Immunol. 10, 1052 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  173. Haley, E. K. et al. The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis. PLoS One 16, e0247149 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  174. Pongratz, G., Straub, R. H., Schölmerich, J., Fleck, M. & Härle, P. Serum BAFF strongly correlates with PsA activity in male patients only-is there a role for sex hormones? Clin. Exp. Rheumatol. 28, 813–819 (2010).

    CAS  PubMed  Google Scholar 

  175. Mollard, E. et al. The impact of menopause on functional status in women with rheumatoid arthritis. Rheumatology 57, 798–802 (2018).

    Article  PubMed  Google Scholar 

  176. Wu, S., Cho, E., Li, W., Grodstein, F. & Qureshi, A. A. Hormonal factors and risk of psoriasis in women: a cohort study. Acta Derm. Venereol. 96, 927–931 (2016).

    Article  PubMed  Google Scholar 

  177. Ceovic, R. et al. Psoriasis: female skin changes in various hormonal stages throughout life — puberty, pregnancy, and menopause. BioMed. Res. Int. 2013, 571912 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  178. Jeong, H. et al. Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model. Arthritis Res. Ther. 19, 198 (2017). An important study reporting the relationship between sex hormones and development of arthritis.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  179. Jeong, H. et al. Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice. Sci. Rep. 11, 11923 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  180. White, H. D. & Robinson, T. D. A novel use for testosterone to treat central sensitization of chronic pain in fibromyalgia patients. Int. Immunopharmacol. 27, 244–248 (2015).

    Article  CAS  PubMed  Google Scholar 

  181. Bartley, E. J. & Fillingim, R. B. Sex differences in pain: a brief review of clinical and experimental findings. Br. J. Anaesth. 111, 52–58 (2013). A Review outlining sex-related differences in pain.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  182. Myers, C. D., Riley, J. L. & Robinson, M. E. Psychosocial contributions to sex-correlated differences in pain. Clin. J. Pain. 19, 225–232 (2003).

    Article  PubMed  Google Scholar 

  183. Eudy, A. M., McDaniel, G. & Clowse, M. E. Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis. Obstet. Med. 13, 70–75 (2020).

    Article  PubMed  Google Scholar 

  184. Bourg, M., Ruyssen-Witrand, A., Bettiol, C. & Parinaud, J. Fertility and sexuality of women with inflammatory arthritis. Eur. J. Obstet. Gynecol. Reprod. Biol. 251, 199–205 (2020).

    Article  PubMed  Google Scholar 

  185. Caldarola, G. et al. Untreated psoriasis impairs male fertility: a case-control study. Dermatol. Basel Switz. 233, 170–174 (2017).

    Article  CAS  Google Scholar 

  186. Ursin, K., Lydersen, S., Skomsvoll, J. F. & Wallenius, M. Psoriatic arthritis disease activity during and after pregnancy: a prospective multicenter study. Arthritis Care Res. 71, 1092–1100 (2019).

    Article  Google Scholar 

  187. Polachek, A. et al. Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls. Clin. Rheumatol. 38, 895–902 (2019).

    Article  PubMed  Google Scholar 

  188. Berman, M. et al. The effect of pregnancy on disease activity in patients with psoriatic arthritis. J. Rheumatol. 45, 1651–1655 (2018).

    Article  PubMed  Google Scholar 

  189. Smith, C. J. F., Bandoli, G., Kavanaugh, A. & Chambers, C. D. Birth outcomes and disease activity during pregnancy in a prospective cohort of women with psoriatic arthritis and ankylosing spondylitis. Arthritis Care Res. 72, 1029–1037 (2020).

    Article  CAS  Google Scholar 

  190. Genest, G., Spitzer, K. A. & Laskin, C. A. Maternal and fetal outcomes in a cohort of patients exposed to tumor necrosis factor inhibitors throughout pregnancy. J. Rheumatol. 45, 1109–1115 (2018).

    Article  PubMed  Google Scholar 

  191. Xie, W., Huang, H., Ji, L. & Zhang, Z. Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Rheumatol. Oxf. Engl. 60, 4018–4028 (2021).

    Article  Google Scholar 

  192. Remaeus, K., Stephansson, O., Johansson, K., Granath, F. & Hellgren, K. Maternal and infant pregnancy outcomes in women with psoriatic arthritis: a Swedish nationwide cohort study. BJOG Int. J. Obstet. Gynaecol. 126, 1213–1222 (2019).

    Article  CAS  Google Scholar 

  193. Eastell, R. et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J. Clin. Endocrinol. Metab. 104, 1595–1622 (2019).

    Article  PubMed  Google Scholar 

  194. Pearson, G. J. et al. 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can. J. Cardiol. 37, 1129–1150 (2021).

    Article  PubMed  Google Scholar 

  195. Vlassoff, C. Gender differences in determinants and consequences of health and illness. J. Health Popul. Nutr. 25, 47–61 (2007).

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Y.-Y.L. has been supported by National Medical Research Council, Singapore (NMRC/CSA-Inv/0022/2017). S.R.J. has been awarded a Canadian Institutes of Health Research New Investigator Award. J.W. receives support from the Arthritis Society Stars Career Development Award (STAR-19-0610). P.R. holds the RTOERO Chair in Geriatric Medicine at the University of Toronto. L.E. has been awarded the Early Researcher Award from the Ontario Ministry of Research, Innovation and Science and Canada Research Chair (Tier 2) in Inflammatory Rheumatic Diseases.

Author information

Authors and Affiliations

  1. Women’s College Research Institute and University of Toronto, Toronto, Ontario, Canada

    Sanjana Tarannum, Paula Rochon & Lihi Eder

  2. Singapore General Hospital and Duke-NUS Medical School, Singapore, Singapore

    Ying-Ying Leung

  3. Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada

    Sindhu R. Johnson

  4. Sunnybrook Research Institute and University of Toronto, Toronto, Ontario, Canada

    Jessica Widdifield

  5. Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USA

    Vibeke Strand

Authors
  1. Sanjana Tarannum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying-Ying Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sindhu R. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jessica Widdifield
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vibeke Strand
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paula Rochon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lihi Eder
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the conception of the manuscript and approved the final version for submission. S.T., Y.-Y.L. and L.E. researched data for the article. S.T. and L.E. wrote the manuscript. All authors reviewed and edited the article. All authors approved the final version for submission.

Corresponding author

Correspondence to Lihi Eder.

Ethics declarations

Competing interests

Y.-Y.L. received an honorarium from AbbVie, DKSH, Janssen, Novartis and Pfizer. V.S. has received consultation fees from AbbVie, Amgen Corporation, Arena, Aria, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, Galapagos, Genentech/Roche, Gilead, GSK, Horizon, Ichnos, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Rheos, Samsung, Sandoz, Sanofi, Sorrento, Sun Pharma, and UCB. L.E. received educational and research grants and consultation fees from AbbVie, UCB, Eli Lily, Novartis, Sandoz and Pfizer. S.R.J., J.W., S.T. and P.R. declare no competing interests.

Peer review

Peer review information

Nature Reviews Rheumatology thanks Kemal Nas and the other, anonymous, reviewer for their contribution to the peer review of this work.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarannum, S., Leung, YY., Johnson, S.R. et al. Sex- and gender-related differences in psoriatic arthritis. Nat Rev Rheumatol 18, 513–526 (2022). https://doi.org/10.1038/s41584-022-00810-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-022-00810-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing